Nevertheless, it is presumed that MYLK‐AS1/hsa‐miR‐195‐5p/CHEK1 and MYLK‐AS1/hsa‐miR‐195‐5p/RASGEF1B regulatory axes play important roles in HCC by regulating cell cycle and immune response. Here, RASGEF1B is linked to hepatocellular carcinoma.